Medindia

X

Diabetes Drug Actos Under Review

by Savitha C Muppala on  June 19, 2011 at 10:30 PM Diabetes News   - G J E 4
Recent reports about the risk of bladder cancer with the diabetes drug pioglitazone, has raised concern and Health Canada is reviewing the status of the drug.
 Diabetes Drug Actos Under Review
Diabetes Drug Actos Under Review
Advertisement

Pioglitazone, which is marketed in Canada under the brand name Actos as well as in generic forms, is prescribed both ways- in combination with other diabetes drugs or exclusively, especially when lifestyle changes like diet and exercise have done little to control blood sugar.

Advertisement
The federal department has confirmed that the safety of this drug is being monitored. Health Canada said that the advantages of consuming pioglitazone is much more than the perceived risks .



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All